Related Experiment Videos

Vitamin E delays diabetes onset in the non-obese diabetic mouse

P E Beales1, A J Williams, M C Albertini

  • 1Department of Diabetes and Metabolism, St. Bartholomew's Hospital, London, United Kingdom.

Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|October 1, 1994
PubMed

Insights

Vitamin E supplementation delayed the onset of Type 1 diabetes in non-obese diabetic mice. However, this antioxidant therapy did not prevent the autoimmune destruction of pancreatic beta cells.

Area of Science:

  • Immunology
  • Endocrinology
  • Nutritional Science

Background:

  • Type 1 diabetes involves the autoimmune destruction of pancreatic beta cells.
  • Non-obese diabetic (NOD) mice are a model for studying Type 1 diabetes.
  • Vitamin E is an antioxidant with potential free radical scavenger activity.

Purpose of the Study:

  • To investigate if Vitamin E administration could prevent or delay Type 1 diabetes in NOD mice.
  • To assess the effect of Vitamin E on insulitis, the autoimmune process targeting pancreatic beta cells.

Main Methods:

  • NOD mice were fed a diet supplemented with Vitamin E or a control diet from 3 to 30 weeks of age.
  • Diabetes incidence and insulitis severity were monitored.
  • Statistical analysis included a parallelism test to assess disease onset delay.

Main Results:

  • Vitamin E did not reduce the overall incidence of diabetes by 30 weeks.
  • Vitamin E significantly delayed the onset of diabetes (p < 0.01).
  • No significant difference in the degree of insulitis was observed between Vitamin E-treated and control groups.

Conclusions:

  • Antioxidant therapy with Vitamin E can delay diabetes onset in NOD mice.
  • Vitamin E's delay of diabetes onset appears independent of its effect on the autoimmune process (insulitis).
  • Further research may explore mechanisms behind Vitamin E's protective effects on beta cell function or survival.

Related Concept Videos